ADT Not Needed With Radiation in Favorable Intermediate-Risk PC
News
Adding four months of androgen deprivation therapy (ADT) to radiation treatment extends survival and delays metastasis in men with unfavorable intermediate-risk prostate cancer, according to a secondary analysis of a Phase ... Read more